Chung LW - Search Results

1

Three distinct regions of allelic loss at 13q14, 13q21-22, and 13q33 in prostate cancer.

Hyytinen ER, Frierson HF Jr, Boyd JC, Chung LW, Dong JT. Hyytinen ER, et al. Among authors: chung lw. Genes Chromosomes Cancer. 1999 Jun;25(2):108-14. Genes Chromosomes Cancer. 1999. PMID: 10337994

2

PTEN/MMAC1 is infrequently mutated in pT2 and pT3 carcinomas of the prostate.

Dong JT, Sipe TW, Hyytinen ER, Li CL, Heise C, McClintock DE, Grant CD, Chung LW, Frierson HF Jr. Dong JT, et al. Among authors: chung lw. Oncogene. 1998 Oct 15;17(15):1979-82. doi: 10.1038/sj.onc.1202119. Oncogene. 1998. PMID: 9788441

3

Loss of heterozygosity and lack of mutations of the XPG/ERCC5 DNA repair gene at 13q33 in prostate cancer.

Hyytinen ER, Frierson HF Jr, Sipe TW, Li CL, Degeorges A, Sikes RA, Chung LW, Dong JT. Hyytinen ER, et al. Among authors: chung lw. Prostate. 1999 Nov 1;41(3):190-5. doi: 10.1002/(sici)1097-0045(19991101)41:3<190::aid-pros6>3.0.co;2-2. Prostate. 1999. PMID: 10517877

4

Genetic changes associated with the acquisition of androgen-independent growth, tumorigenicity and metastatic potential in a prostate cancer model.

Hyytinen ER, Thalmann GN, Zhau HE, Karhu R, Kallioniemi OP, Chung LW, Visakorpi T. Hyytinen ER, et al. Among authors: chung lw. Br J Cancer. 1997;75(2):190-5. doi: 10.1038/bjc.1997.32. Br J Cancer. 1997. PMID: 9010025 Free PMC article.

5

Human prostate cancer expresses the low affinity insulin-like growth factor binding protein IGFBP-rP1.

Degeorges A, Wang F, Frierson HF Jr, Seth A, Chung LW, Sikes RA. Degeorges A, et al. Among authors: chung lw. Cancer Res. 1999 Jun 15;59(12):2787-90. Cancer Res. 1999. PMID: 10383131

6

FOXO1A is a candidate for the 13q14 tumor suppressor gene inhibiting androgen receptor signaling in prostate cancer.

Dong XY, Chen C, Sun X, Guo P, Vessella RL, Wang RX, Chung LW, Zhou W, Dong JT. Dong XY, et al. Among authors: chung lw. Cancer Res. 2006 Jul 15;66(14):6998-7006. doi: 10.1158/0008-5472.CAN-06-0411. Cancer Res. 2006. PMID: 16849544

7

PrLZ, a novel prostate-specific and androgen-responsive gene of the TPD52 family, amplified in chromosome 8q21.1 and overexpressed in human prostate cancer.

Wang R, Xu J, Saramäki O, Visakorpi T, Sutherland WM, Zhou J, Sen B, Lim SD, Mabjeesh N, Amin M, Dong JT, Petros JA, Nelson PS, Marshall FF, Zhau HE, Chung LW. Wang R, et al. Among authors: chung lw. Cancer Res. 2004 Mar 1;64(5):1589-94. doi: 10.1158/0008-5472.can-03-3331. Cancer Res. 2004. PMID: 14996714

8

Trisomy 7: a potential cytogenetic marker of human prostate cancer progression.

Bandyk MG, Zhao L, Troncoso P, Pisters LL, Palmer JL, von Eschenbach AC, Chung LW, Liang JC. Bandyk MG, et al. Among authors: chung lw. Genes Chromosomes Cancer. 1994 Jan;9(1):19-27. doi: 10.1002/gcc.2870090105. Genes Chromosomes Cancer. 1994. PMID: 7507696

9

Convergent RANK- and c-Met-mediated signaling components predict survival of patients with prostate cancer: an interracial comparative study.

Hu P, Chung LW, Berel D, Frierson HF, Yang H, Liu C, Wang R, Li Q, Rogatko A, Zhau HE. Hu P, et al. Among authors: chung lw. PLoS One. 2013 Sep 16;8(9):e73081. doi: 10.1371/journal.pone.0073081. eCollection 2013. PLoS One. 2013. PMID: 24066029 Free PMC article.

10

Establishment of human prostate carcinoma skeletal metastasis models.

Zhau HE, Li CL, Chung LW. Zhau HE, et al. Among authors: chung lw. Cancer. 2000 Jun 15;88(12 Suppl):2995-3001. doi: 10.1002/1097-0142(20000615)88:12+<2995::aid-cncr15>3.3.co;2-p. Cancer. 2000. PMID: 10898343 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

428 results

Search Page